Matrilysin [MMP-7] Expression Selects for Cells with Reduced Sensitivity to Apoptosis
Authors:
- Barbara FingletonBFBarbara Fingleton
- Tracy Vargo-GogolaTVTracy Vargo-Gogola
- Howard C. CrawfordHCHoward C. Crawford
- Lynn M. MatrisianLMLynn M. Matrisian
Open Access
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Matrix metalloproteinases as emerging targets in anticancer therapy: status and prospectsExpert Opinion on Therapeutic Targets, 2000
- Regulation of FasL by NF-κB and AP-1 in Fas-dependent Thymineless Death of Human Colon Carcinoma CellsJournal of Biological Chemistry, 2000
- Induction of matric metalloprotease-7 is common in mucinous ovarian tumors including early stage diseaseMedical Oncology, 2000
- The Hallmarks of CancerCell, 2000
- Differential Activity of Soluble versus Cellular Fas Ligand: Regulation by an Accessory MoleculeCellular Immunology, 1999
- Differential expression of matrilysin and cyclooxygenase-2 in intestinal and colorectal neoplasmsMolecular Carcinogenesis, 1999
- Cleavage of β4 Integrin by MatrilysinExperimental Cell Research, 1997
- Matrilysin: An epithelial matrix metalloproteinase with potentially novel functionsThe International Journal of Biochemistry & Cell Biology, 1996
- Fas and Perforin Pathways as Major Mechanisms of T Cell-Mediated CytotoxicityScience, 1994
- Construction and use of a safe and efficient amphotropic packaging cell lineVirology, 1988